Risk factors for development of pneumothorax in patients with COVID-19 at a government health facility in North India: An exploratory case-control study.

Objective: To explore risk factors for the development of pneumothorax in patients with COVID-19 during the second COVID-19 wave at a northern Indian level 2 health facility. Methods: Patients suffering from SARS-CoV-2 infection during the second wave of the COVID-19 pandemic in India (January-June 2021) at a tertiary care teaching hospital and level 2 COVID care facility were included. Cases who suffered from SARSCoV-2 infection but did not develop pneumothorax were selected as matched controls. All details regarding demographics, clinical presentation, treatment, and outcome were recorded in a semistructured proforma. Results: Eleven patients with COVID-19 developed pneumothorax during the study period and 40 controls were included in the study. Five cases were smokers in comparison to only two in the control group. Type 2 diabetes mellitus was the most common comorbidity among both groups. Median change in C-reactive protein overall for cases and controls were around +14.0 and - 41.9 and was statistically significant. Conclusions: Inflammatory markers like C-reactive protein have significant correlations with the development of pneumothorax in COVID-19-infected patients. There is no sex predisposition to develop pneumothorax among patients with COVID-19. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Acute Disease is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)